MTD Stock Analysis: Buy, Sell, or Hold?

MTD - Mettler-Toledo International

LABORATORY ANALYTICAL INSTRUMENTS
$1373.24
-19.56 (-1.40%) β–Ό
BUY
HIGH Confidence
Last Updated: January 30, 2026
Earnings: Feb 05, 2026 3d

Get Alerted When MTD Hits Your Target Price

Join 10,000+ traders who never miss a move

You're in! Check your email to confirm and set your target price.
100% Free No spam, ever Unsubscribe anytime

Interactive Price Chart (1 Month)

Loading chart...

Loading historical data...

πŸ’‘
Bottom Line:
βœ… BUY SIGNAL: MTD shows strong fundamentals and good volume confirmation. Solid entry point despite oversold pricing.

Long-Term Wealth Forecast (2031)

Based on Analyst Consensus Growth & Historical Valuation

0% (Stagnation) 50% (Hyper Growth)
EST. PRICE IN 2031
$1548.42
Based on 6.3% avg growth
INTRINSIC VALUE TODAY
$961.45
Trading above fair value

How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 25.0x Exit PE.

In-depth Analysis How we analyze

Valuation Analysis: MTD is currently trading at $1373.24, which is considered oversold relative to its 30-day fair value range of $1401.85 to $1472.78. The stock's valuation (Forward PE: 30.0) is in line with its historical norms (31.2). Remarkably, the market is currently pricing in an annual earnings decline of 1.3% over the next few years. This pessimistic expectation contrasts with the company's recent 6.1% earnings growth, suggesting potential undervaluation if the company simply maintains stability.

Technical Outlook: Technically, MTD is in a strong uptrend. The price is currently testing key support at $1363.00. A bounce from this level would confirm strength, while a break below could signal further downside.

Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. In the options market, Implied Volatility is low (0th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.

Quick Decision Summary

Current Position OVERSOLD
Fair Price Range $1401.85 - $1472.78
Company Quality Score 57/100 (HOLD)
Volume Confirmation HIGH
Confidence Score 79.6%

All Signals

  • BULLISH: Price oversold vs 30-day range
  • BULLISH: Options cheap (IV 0th percentile)
  • NEUTRAL: Mixed technical signals (40/100)
  • BULLISH: High volume confirmation
  • NEUTRAL: Near Wall St target ($1504.15)

Fair Price Analysis

30-Day Fair Range $1401.85 - $1472.78
Current vs Fair Value OVERSOLD
Expected Move (7 Days) Β±$69.89 (5.1%)

Support & Resistance Levels

Support Level $1363.00
Resistance Level $1495.80
Current Trend Strong Uptrend

Fundamental Context

Forward P/E (Next Year Est.) 30.01
Wall Street Target $1504.15 (+9.5%)
Revenue Growth (YoY) 7.9%
Earnings Growth (YoY) 6.1%
Profit Margin 21.2%
Valuation Discount vs History -1.3% cheaper
PE vs Historical 30.0 vs 31.2 FAIR
Market-Implied Price Targets If current PE multiple persists
Implied Growth (YoY): -1.3% (market-implied from PE analysis)
1-Year Target $1355.39 (-1%)
2-Year Target $1337.77 (-3%)
3-Year Target $1320.38 (-4%)
3-Yr Target (if PE normalizes) (PE: 30β†’31) $1372.94 (0%)
3-Year Scenarios Using analyst projected EPS growth
Bull: (PE: 30.0, Growth: 8.5%) $1753.25 (+28%)
Base: (SPY PE: 22.3, Growth: 8.5%) $1303.02 (-5%)
Bear: (PE: 19.0, Growth: 8.5%) $1107.56 (-19%)
πŸ“ˆ Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (35x PE), but valuation improves significantly next year (30x PE) as earnings recover.
Trailing PE: 34.96 | Current EPS (TTM): $40.09
Bull Case $1760.11 (+28%)
Analyst growth 14.2%, PE expands to 38.5
Base Case $1600.10 (+17%)
Market implied 14.2%, PE stable at 35.0
Bear Case $953.11 (-31%)
Severe decline -20.0%, PE contracts to 29.7
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
πŸ’‘ Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 30.0 to 31.2
Stabilization Target: $1427.91 (+4.0%)
PE Expansion Potential: +4.0%
Last updated: January 31, 2026 9:38 PM ET
Data refreshes hourly during market hours. Next update: 10:38 PM
πŸ”₯ Top Stocks Breaking Out Now
Ticker Score Recommendation Change %
Insider Activity (6 Months)
0
Buys
4
Sells
Net
INSIDERS SELLING
Recent Transactions
Shawn Vadala SELL 300 shares 2025-08-19
Gerry Keller SELL 165 shares 2025-08-14
Thomas P Salice SELL 1062 shares 2025-08-13

Top Rated Diagnostics & Research Stocks

Top-rated stocks in Diagnostics & Research by analyst ratings.

Stock Analyst Consensus Analyst Target Tradestie Score
TMO
Thermo Fisher Scientific…
STRONG BUY
31 analysts
$653 47 HOLD
EXAS
EXACT Sciences Corporati…
STRONG BUY
26 analysts
$106 57 HOLD
GH
Guardant Health Inc
STRONG BUY
24 analysts
$121 62 BUY
DHR
Danaher Corporation
STRONG BUY
26 analysts
$263 47 HOLD
NTRA
Natera Inc
STRONG BUY
21 analysts
$257 58 HOLD

Advanced MTD Option Strategies

Professional options setups generated by AI based on today's MTD price and gamma walls.

Iron Condor Bull Call Bear Put Collar

More Analysis for MTD

MTD Technical Chart MTD Price Prediction MTD Earnings Date MTD Investment Advisor MTD Fair Price Analyzer MTD Options Advisor MTD Options Chain MTD Options Analysis MTD Competitors
Live Trades
From trading groups
Loading trades...
View All Live Trades See Trader Consensus & Signals